Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD

Conclusions
Faecal metabolic profiling in patients with IBD relative to healthy controls identified MCFAs as important metabolic biomarkers of disease-related changes.

Trial Registration No:
NCT 01666717.

Source: Gut - February 3, 2015 Category: Gastroenterology Authors: De Preter, V., Machiels, K., Joossens, M., Arijs, I., Matthys, C., Vermeire, S., Rutgeerts, P., Verbeke, K. Tags: Crohn's disease Inflammatory bowel disease Source Type: research